Universal Legal acts for Aksigen Hospital Care on the sale of anti-inflammatory brands to Sun Pharma

The deal amount remains undisclosed.

Bar & Bench

Published:3rd Feb, 2023 at 1:48 PM

Aksigen Hospital Care, a research driven pharmaceutical company sold three of its DGCI approved anti-inflammatory brands to drug major Sun Pharmaceutical Industries for an undisclosed amount.

Universal Legal represented Aksigen Hospital Care in this transaction.

The transaction team consisted of Rashi Kapoor Mehta (Partner) and Neelkamal Chaudhary (Associate Partner).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Universal Legal acts for Aksigen Hospital Care on the sale of anti-inflammatory brands to Sun Pharma

The deal amount remains undisclosed.

Also Read

Arbitration is a friend of conferences, foe in practice: Supreme Court

Supreme Court announces changes to mentioning, urgent listing and adjournment rules from December 1

Supreme Court judges, law officers, senior advocates stage Kesavananda Bharati case at JGLS

Delhi HC reinstates RPF constable dismissed for commenting 'Badhiya Kiya Bhai' on FB post about officer’s killing

₹1,000 for lost liberty: The illusory remedy under Section 399 BNSS